Newsroom

Biscayne Pharmaceuticals Merges With Insero Health, Adding Clinical-Stage Novel Epilepsy Program And Other CNS Assets 10.5.15

--Insero Scientific Co-founder and Harvard Epilepsy Expert Dr. Steven Schachter Joins Biscayne as Senior Science Advisor----Drug Development Veteran Stephen Collins Is Named CEO and Launches Series B Financing-- MIAMI BEACH, Fla., Oct. 5, 2015 /PRNewswire/ -- Biscayne Pharmaceuticals, Inc., a...

Exciting News From The Florida Institute 10.1.15

Building Companies, Changing Lives Issue 34- October 2015    Two Companies Receive Institute Funding   The Institute has finalized a first-round funding agreement with Aviana Molecular Technologies (AMT), an Orlando-based company with technology developed at the University of Central...

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon